Pliant Therapeutics (PLRX) Stock Research

Yesterday

Pliant Therapeutics reports Q2 EPS (36c), consensus (34c)

PLRX

Yesterday, 4:24 PM

Over a week ago

Pliant Therapeutics reports Q1 EPS (32c), consensus (36c)

PLRX

May 11, 4:15 PM

Pliant Therapeutics doses first participant in FORTIFY expansion trial

PLRX

Apr 30, 9:35 AM

Pliant announces presentation of updated data from Phase 1 trial of PLN-101095

PLRX

Apr 19, 12:55 PM

Pliant Therapeutics files $300M mixed securities shelf

PLRX

Mar 30, 6:00 PM

Pliant Therapeutics price target lowered by $1 at Canaccord, here's why

PLRX

Mar 13, 7:09 AM

Pliant Therapeutics price target lowered by $1 at Piper Sandler, here's why

PLRX

Mar 12, 7:09 AM

Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)

PLRX

Mar 11, 4:20 PM

Pliant Therapeutics announces interim data from PLN-101095

PLRX

Dec 4, 7:34 AM

Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)

PLRX

Nov 6, 6:42 PM

Buy/Sell: Wall Street's top 10 stock calls this week

+10

Oct 10, 1:58 PM

Align downgraded, NetEase upgraded: Wall Street's top analyst calls

+12

Oct 10, 9:36 AM

Pliant Therapeutics just downgraded at JPMorgan, here's why

PLRX

Oct 10, 5:04 AM

No more stories